News

Antipathy from figures close to Trump toward mRNA technology, which underlies Moderna’s products and pipeline, has weighed on ...
Scientists used IBM's R2 Heron quantum processor to predict the secondary protein structure of a 60-nucleotide-long mRNA ...
Six months into Donald Trump’s second term, his administration is at war with the federal judiciary, evading court orders ...
This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
Perhaps the most critical aspect of Moderna's business to pay attention to right now is its late-stage pipeline. The company ...
US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...
The U.S. health secretary ordered an end to new mRNA development efforts just after UTMB published new research showing its ...
Biotechnology company Moderna (NASDAQ:MRNA) reported Q2 CY2025 results exceeding the market’s revenue expectations, but sales ...
Adams, who served as surgeon general during the first Trump administration, said Kennedy's assertions about the efficacy of ...